•
Jun 30, 2023

ImmunityBio Q2 2023 Earnings Report

Total Revenue
$41K
Previous year: $35K
+17.1%
EPS
-$0.32
Previous year: -$0.24
+33.3%
Gross Profit
-$6.28M
Previous year: -$5.9M
+6.5%
Cash and Equivalents
$43.5M
Previous year: $61.9M
-29.7%
Free Cash Flow
-$88.3M
Previous year: -$107M
-17.6%
Total Assets
$291M
Previous year: $318M
-8.3%

ImmunityBio

ImmunityBio

ImmunityBio Revenue by Segment